Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VPOP2: Droperidol for Postoperative Vomiting Prophylaxis in Children
NCT01739985Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of droperidol in postoperative nausea and vomiting (PONV), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Postoperative Vomiting at 24 hours. Started Dec 2010; status: completed.
02
Drugs
droperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT01739985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01739985.